Atomwise

AI for Drug Discovery.

Visit Website →

Overview

Atomwise is a preclinical pharma company that has developed a machine learning-based discovery engine combining convolutional neural networks with extensive chemical libraries to discover new small molecule medicines. Their AtomNet® technology is designed to unlock more undruggable targets than other AI drug discovery platforms by screening billions of compounds to identify those with the highest potential to treat specific diseases.

✨ Key Features

  • AtomNet® deep learning platform
  • Structure-based drug design
  • Virtual screening of billions of compounds
  • Hit identification and lead optimization
  • Binding affinity prediction

🎯 Key Differentiators

  • Pioneered the use of deep learning for structure-based drug discovery.
  • AtomNet® technology for rapid screening of billions of compounds.

Unique Value: Accelerates the identification of novel small molecule drug candidates through its proprietary deep learning platform.

🎯 Use Cases (4)

Small molecule drug discovery Identifying hits for undruggable targets Lead optimization Drug repurposing

✅ Best For

  • Identifying drug candidates for various diseases including Ebola and multiple sclerosis.

💡 Check With Vendor

Verify these considerations match your specific requirements:

  • Large molecule (biologics) discovery

🏆 Alternatives

Schrödinger Insilico Medicine Recursion Pharmaceuticals

Offers a more rapid and efficient approach to hit identification compared to traditional high-throughput screening methods.

💻 Platforms

Web API

🔌 Integrations

API

🛟 Support Options

  • ✓ Email Support
  • ✓ Phone Support
  • ✓ Dedicated Support (Enterprise tier)

💰 Pricing

Contact for pricing

Free tier: NA

Visit Atomwise Website →